Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Cash from Investing Activities (2020 - 2025)

Bioventus' Cash from Investing Activities history spans 6 years, with the latest figure at -$580000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 102.41% year-over-year to -$580000.0; the TTM value through Dec 2025 reached -$3.2 million, down 114.14%, while the annual FY2025 figure was -$3.2 million, 114.14% down from the prior year.
  • Cash from Investing Activities reached -$580000.0 in Q4 2025 per BVS's latest filing, down from -$473000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $48.5 million in Q4 2022 to a low of -$221.3 million in Q4 2021.
  • Average Cash from Investing Activities over 5 years is -$18.2 million, with a median of -$1.2 million recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: crashed 12832.67% in 2021, then soared 467.87% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$221.3 million in 2021, then surged by 51.08% to -$108.2 million in 2022, then skyrocketed by 88.82% to -$12.1 million in 2023, then surged by 299.26% to $24.1 million in 2024, then plummeted by 102.41% to -$580000.0 in 2025.
  • Per Business Quant, the three most recent readings for BVS's Cash from Investing Activities are -$580000.0 (Q4 2025), -$473000.0 (Q3 2025), and -$1.4 million (Q2 2025).